Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1999-07-01 (26 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-HILAIRE (11250), Aude
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BURLAN LECLERCQ : revenue, balance sheet and financial ratios
PHARMACIE BURLAN LECLERCQ is a French company
founded 26 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-HILAIRE (11250),
this company of category PME
shows in 2024 a net income positive of 26 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BURLAN LECLERCQ (SIREN 423805738)
Indicator
2024
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
25 524 €
78 311 €
54 500 €
48 162 €
40 316 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE BURLAN LECLERCQ generates positive net income of 26 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 40 k€ -> 26 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
25 524 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1336%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1335.818%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
5.613%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2024
Debt ratio
920.496
762.656
664.558
477.591
1335.818
Financial autonomy
7.989
9.455
10.577
13.651
5.613
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
1335.822024
2021
2022
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE BURLAN LECLERCQ (1335.82) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
5.61%2024
2021
2022
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE BURLAN LECLERCQ (5.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 56.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2024
Liquidity ratio
82.064
73.578
68.267
85.396
56.527
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
56.532024
2021
2022
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch
In 2024, the liquidity ratio of PHARMACIE BURLAN LECLERCQ (56.53) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE BURLAN LECLERCQ in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE BURLAN LECLERCQ is estimated at
356 333 €
(range 248 145€ - 533 095€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
248k€356k€533k€
356 333 €Range: 248 145€ - 533 095€
NAF 5 année 2024
Valuation method used
Net Income Multiple
25 524 €
×
14.0x
=356 334 €
Range: 248 145€ - 533 096€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BURLAN LECLERCQ with other companies in the same sector:
Frequently asked questions about PHARMACIE BURLAN LECLERCQ
What is the revenue of PHARMACIE BURLAN LECLERCQ ?
The revenue of PHARMACIE BURLAN LECLERCQ is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BURLAN LECLERCQ profitable?
Yes, PHARMACIE BURLAN LECLERCQ generated a net profit of 26 k€ in 2024.
Where is the headquarters of PHARMACIE BURLAN LECLERCQ ?
The headquarters of PHARMACIE BURLAN LECLERCQ is located in SAINT-HILAIRE (11250), in the department Aude.
Where to find the tax return of PHARMACIE BURLAN LECLERCQ ?
The tax return of PHARMACIE BURLAN LECLERCQ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BURLAN LECLERCQ operate?
PHARMACIE BURLAN LECLERCQ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart